# Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets

> **NCT00417612** · PHASE3 · COMPLETED · sponsor: **Yale University** · enrollment: 33 (actual)

## Conditions studied

- Hypophosphatemia, Familial
- Hyperparathyroidism

## Interventions

- **DRUG:** Paricalcitol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00417612
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417612, "Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00417612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*